Oral Squamous Cell CarcinomaSymptoms, Doctors, Treatments, Advances & More
Oral Squamous Cell Carcinoma Overview
Learn About Oral Squamous Cell Carcinoma
Appalachian Radiation Oncology Associates PC
Kyle Colvett is a Radiation Oncologist practicing medicine in Johnson City, Tennessee. Dr. Colvett is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Laryngeal Cancer, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Colvett is board certified in American Board Of Radiology.
Avera Medical Group ENT — Head & Neck Surgery — Plaza 1
Dr. Mark Jameson is an otolaryngologist at Avera Medical Group Ear Nose & Throat in Sioux Falls, SD. Dr. Jameson is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Sinus Cancer, Teratocarcinosarcoma, Olfactory Neuroblastoma, Laryngectomy, and Gastrostomy. Dr. Jameson is board certified in American Board Of Otolaryngology – Head And Neck Surgery.
Avera Medical Group ENT — Head & Neck Surgery — Plaza 1
Dr. W. Chad Spanos is an otolaryngologist at Avera Medical Group ENT - Head &Neck Surgery in Sioux Falls, SD. Dr. Spanos is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Parathyroid Hyperplasia, Laryngeal Cancer, Hyperparathyroidism, Thyroidectomy, and Gastrostomy. Dr. Spanos is board certified in American Board Of Otolaryngology.
Summary: The purpose of this study is to determine whether cervical lymph node dissection is necessarily performed in the presence of early-stage oral squamous cell carcinoma.
Summary: This is a multicenter, open-label, randomized phase III clinical trial evaluating perioperative treatment with sintilimab combined with chemotherapy in patients with locally advanced oral squamous cell carcinoma. Despite standard treatment with surgery followed by postoperative radiotherapy or chemoradiotherapy, patients with locally advanced oral squamous cell carcinoma remain at high risk of rec...


